Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them. Send request. ×

Active ingredient:

OLANZAPINE 15 MG

Available from:

SALOMON,LEVIN & ELSTEIN LTD

ATC code:

N05AH03

Pharmaceutical form:

FILM COATED TABLETS

Administration route:

PER OS

Manufactured by:

TEVA OPERATIONS POLAND SP.ZO.O

Therapeutic group:

OLANZAPINE

Therapeutic indications:

Acute and maintenance treatment of schizophrenia. Olanzapine Teva® is indicated for the management of the manifestations of psychotic disorders. Olanzapine Teva® is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.Prevention of recurrence in Bipolar Disorder: In patients whose manic episode has responded to olanzapine treatment Olanzapine Teva® is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder. The combination of Olanzapine Teva® with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

Authorization number:

145733319000

Authorization date:

2011-04-01